Incyte Corp (INCY)
54.39
+0.31
(+0.57%)
USD |
NASDAQ |
May 07, 16:00
54.39
0.00 (0.00%)
After-Hours: 18:22
Incyte Gross Profit (TTM): 3.509B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 3.509B |
December 31, 2023 | 3.441B |
September 30, 2023 | 3.365B |
June 30, 2023 | 3.274B |
March 31, 2023 | 3.249B |
December 31, 2022 | 3.188B |
September 30, 2022 | 3.139B |
June 30, 2022 | 3.143B |
March 31, 2022 | 2.950B |
December 31, 2021 | 2.835B |
September 30, 2021 | 2.770B |
June 30, 2021 | 2.583B |
March 31, 2021 | 2.570B |
December 31, 2020 | 2.535B |
September 30, 2020 | 2.329B |
June 30, 2020 | 2.265B |
March 31, 2020 | 2.110B |
December 31, 2019 | 2.045B |
September 30, 2019 | 1.999B |
June 30, 2019 | 1.903B |
March 31, 2019 | 1.899B |
December 31, 2018 | 1.788B |
September 30, 2018 | 1.708B |
June 30, 2018 | 1.642B |
March 31, 2018 | 1.452B |
Date | Value |
---|---|
December 31, 2017 | 1.457B |
September 30, 2017 | 1.342B |
June 30, 2017 | 1.232B |
March 31, 2017 | 1.159B |
December 31, 2016 | 1.048B |
September 30, 2016 | 974.79M |
June 30, 2016 | 905.10M |
March 31, 2016 | 827.91M |
December 31, 2015 | 726.75M |
September 30, 2015 | 614.15M |
June 30, 2015 | 632.50M |
March 31, 2015 | 575.17M |
December 31, 2014 | 508.49M |
September 30, 2014 | 483.85M |
June 30, 2014 | 370.89M |
March 31, 2014 | 373.02M |
December 31, 2013 | 354.32M |
September 30, 2013 | 371.16M |
June 30, 2013 | 346.65M |
March 31, 2013 | 331.66M |
December 31, 2012 | 296.90M |
September 30, 2012 | 212.04M |
June 30, 2012 | 168.37M |
March 31, 2012 | 98.65M |
December 31, 2011 | 94.46M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
1.903B
Minimum
Jun 2019
3.509B
Maximum
Mar 2024
2.760B
Average
2.802B
Median
Gross Profit (TTM) Benchmarks
Biogen Inc | 7.250B |
Novartis AG | 36.35B |
MorphoSys AG | 194.83M |
Illumina Inc | 2.757B |
Pfizer Inc | 31.64B |